You are here

Stroke/TIA Research Studies

 

Platelet-oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT)

PI:  Fazeel Siddiqui, MD

Study Contact:  Laura Golden, RN          217.545.2261

 

 


 

 

Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, oral b.i.d.) Versus Acetylsalicylic Acid (100 mg oral q.d.) in Patients With Embolic Stroke of Undetermined Source (RESPECT-ESUS)

PI:  Fazeel Siddiqui, MD

Study Contact:  Laura Golden, RN          217.545.2261